Research Progress on Cardiotoxicity of PD-1/PD-L1 Immune Checkpoint Inhibitors

Cardiotoxicity is a serious complication of antineoplastic drugs. With the continuous development of antineoplastic drugs, immune checkpoint inhibitors have been used in the treatment of a variety of cancers. PD-1/PD-L1 immune checkpoint inhibitors have been widely concerned in recent years. This ar...

Full description

Bibliographic Details
Main Authors: YU Lin, LI Guangping, ZHOU Changyu, FU Huaying
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2021-08-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
Online Access:http://www.zlfzyj.com/EN/abstract/abstract9878.shtml